← brief for 2026-09-10 · Regeneration & devices

Continuous biosensing and real-time metabolic monitoring in obesity, diabetes, and diabetic kidney disease: implications for precision diabetes and kidney care

Key takeaways

This review covers wearable sensors that track blood sugar and other body chemistry continuously in people with obesity, diabetes and diabetic kidney disease. The authors argue that constant readings could make treatment more personal. It is a discussion of where the technology is heading, not a trial, so there are no results showing it protects kidneys yet.

Who did this work

Amin Roshdy Soliman (Cairo University) · Mohamed Momtaz A. Elaziz (Cairo University) · Ghada Ayeldeen (Cairo University) · Ahmed Fayed (Cairo University)

Source

Paper · OpenAlex, CKD works · 2026-09-09
https://doi.org/10.1186/s43162-026-00721-z